Rocket Pharmaceuticals Inc’s filing revealed that its CEO Shah Gaurav unloaded Company’s shares for reported $0.23 million on May 16 ’24. In the deal valued at $23.35 per share,9,790 shares were sold. As a result of this transaction, Shah Gaurav now holds 728,069 shares worth roughly $16.51 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Patel Kinnari sold 4,046 shares, generating $94,474 in total proceeds. Upon selling the shares at $23.35, the insider now owns 400,972 shares.
Before that, Militello John sold 1,079 shares. Rocket Pharmaceuticals Inc shares valued at $25,195 were divested by the insider at a price of $23.35 per share. As a result of the transaction, Militello John now holds 53,327 shares, worth roughly $1.21 million.
Goldman initiated its Rocket Pharmaceuticals Inc [RCKT] rating to a Neutral in a research note published on April 02, 2024; the price target was $39. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late October with a ‘”an Overweight”‘ rating. Morgan Stanley began covering RCKT with “an Overweight” recommendation on February 01, 2023. Canaccord Genuity started covering the stock on November 08, 2022. It rated RCKT as “a Buy”.
Price Performance Review of RCKT
On Friday, Rocket Pharmaceuticals Inc [NASDAQ:RCKT] saw its stock fall -1.35% to $22.68. Over the last five days, the stock has gained 6.38%. Rocket Pharmaceuticals Inc shares have fallen nearly -24.32% since the year began. Nevertheless, the stocks have fallen -2.28% over the past one year. While a 52-week high of $32.53 was reached on 02/27/24, a 52-week low of $14.89 was recorded on 05/29/24. SMA at 50 days reached $23.28, while 200 days put it at $23.82. A total of 0.51 million shares were traded, compared to the trading of 0.61 million shares in the previous session.
Levels Of Support And Resistance For RCKT Stock
The 24-hour chart illustrates a support level at 22.29, which if violated will result in even more drops to 21.90. On the upside, there is a resistance level at 23.14. A further resistance level may holdings at 23.60. The Relative Strength Index (RSI) on the 14-day chart is 50.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.92, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 22.33%. Stochastics %K at 81.27% indicates the stock is a selling.
The most recent change occurred on November 01, 2022 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $35 price target.
